Samsung Biologics Co.,Ltd. (KRX: 207940)

Samsung Biologics Co.,Ltd. Market Cap

Samsung Biologics Co.,Ltd. has a market cap or net worth of 65.20 trillion as of November 18, 2024. Its market cap has increased by 24.12% in one year.

• Market Cap: 65.20T
• Enterprise Value: 65.31T
• Revenue: 4.21T
• Ranking: n/a
• PE Ratio: 63.39
• Stock Price: 937,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics Co.,Ltd.'s market cap has increased from 9.53T to 65.20T, an increase of 584.27%. That is a compound annual growth rate of 27.07%.

Market Cap History

Date	Market Cap	% Change
Nov 18, 2024	65.20T	20.53%
Dec 28, 2023	54.09T	-7.43%
Dec 29, 2022	58.43T	-2.20%
Dec 30, 2021	59.75T	9.32%
Dec 30, 2020	54.65T	90.76%
Dec 30, 2019	28.65T	12.03%